Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells.

Saved in:
Bibliographic Details
Title: Co-editing of NKG2A and FAS increases long-term cytotoxic capacity and persistence of CAR NK cells.
Authors: Mietz J; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Egli L; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Misiune M; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Picozzi A; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Coianiz N; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Thompson D; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Ponzo M; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Charmey A; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland., Bornhauser B; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland., Magnani CF; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Chijioke O; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Jan 09; Vol. 34 (1), pp. 201126. Date of Electronic Publication: 2026 Jan 09 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-3299
DOI:10.1016/j.omton.2026.201126